Mitochondrial biogenesis: a potential therapeutic target for osteoarthritis

被引:29
|
作者
Blanco, F. J. [1 ,2 ]
Fernandez-Moreno, M. [2 ,3 ]
机构
[1] Complexo Hosp Univ A Coruna CHUAC, Agrupac Estrateg CICA INIBIC, Inst Invest Biomed A Coruna INIBIC, Grp Invest Reumatol, Sergas, Spain
[2] Univ A Coruna UDC, Dept Med, La Coruna, Spain
[3] Ctr Invest Biomed Red Bioingn Biomat & Nanomed CI, Madrid, Spain
关键词
Mitochondrial dynamics; Mfn2; Osteoarthritis; MITOFUSIN; 2; ENDOPLASMIC-RETICULUM; DYNAMICS; PARKIN; FISSION; FUSION; MFN2;
D O I
10.1016/j.joca.2020.03.018
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Mitochondrial dysfunction of human articular chondrocytes is considered a hallmark of cartilage degradation and OA pathogenesis. Due to the huge number of cellular processes in which mitochondria is implicated, even in the closed context of cellular respiration, the term mitochondrial function can refer to a variety of features which include fusion and fission, turnover (biogenesis and mitophagy), and plasticity. Mitochondrial biogenesis and mainly mitochondrial fusion and reduced mitophagy, contribute to the metabolic disorder and inflammation that occurs during OA. Reduced MFN2 and increased PARKIN expression represent potential therapeutic targets for the treatment of joint cartilage degradation during the OA process. (c) 2020 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1003 / 1006
页数:4
相关论文
共 50 条
  • [41] FGA can be used as a promising therapeutic target in osteoarthritis
    Guanhong Chen
    Han Zhang
    Xizhuang Bai
    BMC Musculoskeletal Disorders, 26 (1)
  • [42] BMP signaling: A significant player and therapeutic target for osteoarthritis
    Jaswal, Akrit Pran
    Kumar, Bhupendra
    Roelofs, Anke J.
    Iqbal, Sayeda Fauzia
    Singh, Amaresh Kumar
    Riemen, Anna H. K.
    Wang, Hui
    Ashraf, Sadaf
    Nanasaheb, Sanap Vaibhav
    Agnihotri, Nitin
    De Bari, Cosimo
    Bandyopadhyay, Amitabha
    OSTEOARTHRITIS AND CARTILAGE, 2023, 31 (11) : 1454 - 1468
  • [43] Macrophage polarization in osteoarthritis progression: a promising therapeutic target
    Zhang, Yanlei
    Ji, Quanbo
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [44] Mitochondrial homeostasis regulation: A promising therapeutic target for Parkinson's disease
    Yao, Meng-Fan
    Dang, Tao
    Wang, Hua-Jun
    Zhu, Xiao-Zhong
    Qiao, Chen
    BEHAVIOURAL BRAIN RESEARCH, 2024, 459
  • [45] Mitochondrial Dysfunction as a Signaling Target for Therapeutic Intervention in Major Neurodegenerative Disease
    Mangrulkar, Shubhada V. V.
    Wankhede, Nitu L. L.
    Kale, Mayur B. B.
    Upaganlawar, Aman B. B.
    Taksande, Brijesh G. G.
    Umekar, Milind J. J.
    Anwer, Md. Khalid
    Dailah, Hamad Ghaleb
    Mohan, Syam
    Behl, Tapan
    NEUROTOXICITY RESEARCH, 2023, 41 (06) : 708 - 729
  • [46] Mitochondrial dynamics, a new therapeutic target for Triple Negative Breast Cancer
    Weiner-Gorzel, K.
    Murphy, M.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1875 (02):
  • [47] Mitochondrial Dysfunction as a Signaling Target for Therapeutic Intervention in Major Neurodegenerative Disease
    Shubhada V. Mangrulkar
    Nitu L. Wankhede
    Mayur B. Kale
    Aman B. Upaganlawar
    Brijesh G. Taksande
    Milind J. Umekar
    Md. Khalid Anwer
    Hamad Ghaleb Dailah
    Syam Mohan
    Tapan Behl
    Neurotoxicity Research, 2023, 41 : 708 - 729
  • [48] HIF-2α as a possible therapeutic target of osteoarthritis
    Saito, T.
    Kawaguchi, H.
    OSTEOARTHRITIS AND CARTILAGE, 2010, 18 (12) : 1552 - 1556
  • [49] Stromal cell-derived factor-1 as a potential therapeutic target for osteoarthritis and rheumatoid arthritis
    Bragg, Robert
    Gilbert, William
    Elmansi, Ahmed M.
    Isales, Carlos M.
    Hamrick, Mark W.
    Hill, William D.
    Fulzele, Sadanand
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2019, 10
  • [50] The Mitochondrial Dynamics of Alzheimer's Disease and Parkinson's Disease Offer Important Opportunities for Therapeutic Intervention
    Bonda, David J.
    Smith, Mark A.
    Perry, George
    Lee, Hyoung-gon
    Wang, Xinglong
    Zhu, Xiongwei
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (31) : 3374 - 3380